The Future of Biobetters: Aarkstore

1
The Future of Biobetters
2
PDF -  2245
How can you successfully position biobetter
products in the increasingly crowded branded
biologic/biosimilar space? With the prospect of
improving patient adherence, meeting unmet
clinical need and increasing revenues, investment
in the biobetter pipeline has grown rapidly. Yet
biobetter products need to bring some serious
clinical and cost saving advantages if they are
to get stakeholder support and make a return on
investment. Success depends on navigating an
undefined regulatory pathway, avoiding IP
minefields and ultimately persuading stakeholders
that the benefits are worth the cost. 
3
Report Overview In The Future of Biobetters,
senior industry experts from leading pharma
companies and organisations identify the
challenges facing this emerging sector and
provide practical and actionable insights for
achieving commercial success. 
4
Report Features

• Unique insights from US and EU experts in
  companies such as Takeda, Eisai and MedImmune 
• Table showing the technologies that can be
  applied in biobetter development
• Graph illustrating EU5US sales of key biologics
  scheduled to lose patent protection in 2015-2020
• Chart demonstrating how biobetter development
  requires more analytical capabilities versus
  originator biologic development
• Case Study Developing a biobetter before an
  originators patent expiry lessons from Roche

5

• Case Study Pulling potential biobetters out of
  the freezer Takeda Oncology using advanced
  technology to reinvigorate a failed biologic
  projects
• Case Study Competition between biobetters Amgen
  and Teva go head-to-head
• Case Study How overpricing of biobetters can
  make stakeholders lose trust in a company Vertex
• Pharmaceuticals Orkambi experience
• At-a-glance summaries of all the key takeaways. 

6
Key Benefits

• Identify the advantages of biobetters, the value
  they present, and their competitive position in
  the branded biologic/biosimilar market 
• Examine how biobetters can meet unmet clinical
  need and improve patient outcomes
• Understand the current regulatory situation and
  how this is impacting biobetter development
• Investigate potential intellectual property
  issues that may challenge the sector
• Critically appraise biobetter pricing and
  identify factors that will deliver optimum
  returns
• Assess the potential for advances in technology
  and analytical tools to reinvigorate previously
  failed biologic projects

7
Table of Contents
1.Executive Summary 2.Experts interviewed 3.The
landscape of biological medicines 4. Marketing
acceptance of biobetters 5.SWOT Analysis 6. The
implications of competing with originators and
biosimilars 7. Challenges in biobetter
development and uptake 8. Putting a price on the
value of biobetters 9. Future opportunities in
the biobetter space 10.Predictions for biobetter
development 11.Conclusion 12.Appendix
8
Browse Full Report _at_ http//www.aarkstore.com/heal
thcare/452802/the-future-of-biobetters
Order Free Sample Request _at_ http//www.aarkstore.c
om/sample/452802
More Related Reports _at_ http//www.aarkstore.com/he
althcare
Get Custom research Reports _at_ http//www.aarkstore
.com/custom-research.php
9
Aarkstore Enterprise belongs to the leading
resellers of Market Research Reports on global
range. Started in 2008 with high branding of
prime industries and business expertise,
Aarkstore Enterprise now is relied upon for
calculated market research reports and business
solutions. Our approach and branding of
industry and market has effortlessly led to
global accreditation wherein Aarkstore is placed
amongst the top report resellers.
10
Contact Us -
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756
4953